Previous studies also showed that a single dose of GLP-1 inhibits the postprandial rise in triglycerides and free fatty acids in healthy persons [25] and inhibits the postprandial rise in triglycerides and apolipoprotein B48 in patients with T2DM [26]. Here, APOB is linked to type 2 diabetes mellitus.